Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 38051 - 38075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	PALLD	23022	downregulated	entinostat results in decreased expression of PALLD mRNA	4q32.3	A21037
Entinostat	Investigational	PALLD	23022	upregulated	entinostat results in increased expression of PALLD mRNA	4q32.3	A21035
Entinostat	Investigational	PALM3	342979	upregulated	entinostat results in increased expression of PALM3 mRNA	19p13.12	A21037 A21035
Entinostat	Investigational	PAMR1	25891	downregulated	entinostat results in decreased expression of PAMR1 mRNA	11p13	A21037
Entinostat	Investigational	PAPLN	89932	upregulated	entinostat results in increased expression of PAPLN mRNA	14q24.2	A21037
Entinostat	Investigational	PAPPA	5069	upregulated	entinostat results in increased expression of PAPPA mRNA	9q33.1	A21037 A21035
Entinostat	Investigational	PAQR5	54852	upregulated	entinostat results in increased expression of PAQR5 mRNA	15q23	A21037 A21035
Entinostat	Investigational	PARP12	64761	upregulated	entinostat results in increased expression of PARP12 mRNA	7q34	A21037 A21035
Entinostat	Investigational	PARP8	79668	downregulated	entinostat results in decreased expression of PARP8 mRNA	5q11.1	A21037
Entinostat	Investigational	PARVA	55742	downregulated	entinostat results in decreased expression of PARVA mRNA	11p15.3	A21037
Entinostat	Investigational	PATJ	10207	upregulated	entinostat results in increased expression of PATJ mRNA	1p31.3	A21035
Entinostat	Investigational	PATZ1	23598	downregulated	entinostat results in decreased expression of PATZ1 mRNA	22q12.2	A21035
Entinostat	Investigational	PAX2	5076	upregulated	entinostat results in increased expression of PAX2 mRNA	10q24.31	A21037
Entinostat	Investigational	PAX3	5077	upregulated	entinostat results in increased expression of PAX3 mRNA	2q36.1	A21037
Entinostat	Investigational	PAX5	5079	upregulated	entinostat results in increased expression of PAX5 mRNA	9p13.2	A21037
Entinostat	Investigational	PAX6	5080	downregulated	entinostat results in decreased expression of PAX6 mRNA	11p13	A21037
Entinostat	Investigational	PBX2	5089	downregulated	entinostat results in decreased expression of PBX2 mRNA	6p21.32	A21035
Entinostat	Investigational	PCBD2	84105	upregulated	entinostat results in increased expression of PCBD2 mRNA	5q31.1	A21037
Entinostat	Investigational	PCDH10	57575	upregulated	entinostat results in increased expression of PCDH10 mRNA	4q28.3	A21037
Entinostat	Investigational	PCDH17	27253	downregulated	entinostat results in decreased expression of PCDH17 mRNA	13q21.1	A21035
Entinostat	Investigational	PCDH18	54510	downregulated	entinostat results in decreased expression of PCDH18 mRNA	4q28.3	A21035
Entinostat	Investigational	PCDH20	64881	upregulated	entinostat results in increased expression of PCDH20 mRNA	13q21.2	A21037
Entinostat	Investigational	PCDH8	5100	upregulated	entinostat results in increased expression of PCDH8 mRNA	13q14.3	A21037
Entinostat	Investigational	PCDH9	5101	downregulated	entinostat results in decreased expression of PCDH9 mRNA	13q21.32	A21035
Entinostat	Investigational	PCDHA2	56146	downregulated	entinostat results in decreased expression of PCDHA2 mRNA	5q31.3	A21037

Displaying entries 38051 - 38075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability